Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
7,341 total articles
Madrigal Pharmaceuticals President and CEO William John Sibold sold 1,663 shares on March 6 to satisfy tax-withholding obligations tied to restricted stock units, generating proceeds of $718,316. The sale was non-discretionary, according to a SEC Form 4 filing. Madrigal recently reported a fourth-quarter 2025 earnings-per-share shortfall even as re…
Energy Recovery Chief Technology Officer Natarajan Ramanan sold 272 shares of the company’s common stock on March 5, 2026, for $10.57 per share, a transaction valued at $2,875. The sale was filed on a Form 4 with the Securities and Exchange Commission and was executed under a power of attorney, with William Yeung signing on Ramanan’s behalf. The tr…
LTC Properties director David L. Gruber acquired 7,000 shares of common stock on March 5, 2026, spending $266,000 at $38.00 per share. The transaction comes as the REIT trades close to its 52-week high and amid mixed quarterly results that included an EPS beat-in-line and a substantial revenue miss, as LTC pursues Senior Housing Operating Partnersh…
Madrigal Pharmaceuticals' general counsel, Kelley Shannon T, sold 360 shares on March 6, 2026, for $431.94 each, totaling $155,498. Recent SEC filings show additional stock activity and option grants earlier in March, while the company reported a Q4 2025 earnings shortfall on EPS but revenue above expectations and continued strong sales from its le…
Kinetik Holdings Inc. (NASDAQ: KNTK) Chief Financial Officer Trevor Howard sold 1,619 shares of Class A common stock on March 4, 2026, in a Form 4 filing. The shares were sold at $46.92 each for a total of $75,963 to satisfy tax withholding tied to vested shares awarded in lieu of cash for the 2025 annual incentive. After the sale Howard directly o…
Lindsay Ellis, Kinetik Holdings Inc.'s General Counsel, Chief Compliance Officer and Corporate Secretary, sold 1,260 shares of Class A common stock on March 4, 2026, to satisfy tax-withholding obligations tied to the vesting of equity awards. The trade totaled $59,119 at $46.92 per share. The transaction occurs amid a 29% year-to-date share gain an…
Steven Stellato, Kinetik Holdings Inc.'s executive vice president, chief accounting officer and administrative officer, sold 2,907 shares of Class A Common Stock on March 4, 2026, at $46.92 per share, resulting in proceeds of $136,396. The transaction was conducted to satisfy tax withholding tied to the vesting of shares issued in lieu of cash for …
Suma Krishnan, a director and President, R&D at Krystal Biotech, sold 23,799 shares of the company's common stock on March 4, 2026, in a series of transactions that generated roughly $6.58 million in proceeds. The disposals were executed under a Rule 10b5-1 trading plan adopted in September 2025. Separately, Krystal Biotech reported fourth-quarter …
Kinetik Holdings Inc. Chief Operating Officer Matthew Wall sold 3,222 Class A shares on March 4, 2026 to satisfy tax withholding tied to the vesting of compensation from the 2025 annual incentive award. The transaction totaled $151,176 based on a $46.92 sale price. The stock is trading around $45.60 and has risen 29% year-to-date amid mixed quarter…
MaxLinear Inc. Chief Financial Officer and Chief Corporate Strategy Officer Steven G. Litchfield reported sales of company stock totaling $746,427 over three consecutive days in early March 2026, according to a Form 4 filing. The transactions reduced his direct holdings to 343,435 shares. The share sales occurred amid recent downward pressure on th…
Yelp Chief Operating Officer Joseph R. Nachman executed a pre-arranged sale of 2,499 shares on March 6, 2026, for roughly $60,450, according to a Form 4 filing. The transaction followed a recent grant of performance-based restricted stock units and comes amid active share repurchases, a recent quarterly beat, tempered guidance, and divergent analys…
FormFactor Inc. CFO and SVP Global Finance Aric Brendan McKinnis sold 3,462 shares on March 5, 2026 under a Rule 10b5-1 plan, generating $313,034. The transaction follows recent share price swings even as the company reported better-than-expected fourth-quarter results and carries a market capitalization of $6.59 billion.
Tidewater Inc. Executive Vice President, Chief Financial Officer and Chief Administrative Officer Rubio Samuel R sold 22,461 shares of Tidewater common stock on March 5, 2026, generating proceeds of $1,798,003. The transaction occurred at prices between $80.01 and $80.51. The sale follows a year in which Tidewater shares have climbed nearly 90% and…
Daniel A. Hudson, Executive Vice President and General Counsel of Tidewater (NYSE:TDW), sold 5,195 shares of the company's common stock on March 5, 2026 for a total of $418,509. The transaction occurred amid Tidewater's stronger-than-expected fourth-quarter 2025 financial performance and a Raymond James price-target increase to $117.
Sheri B. Bronstein, Bank of America’s Chief People Officer, sold 60,000 shares on March 5, 2026, generating $2.99 million at weighted average prices between $49.65 and $50.24. The bank has several concurrent capital and strategic actions, including a Yen-denominated note redemption, new bond issuance, a role in an IPO, a data partnership with the L…
Innospec Executive Vice President and CFO Ian Cleminson sold 2,380 shares of the company's common stock on February 27, 2026, through a series of transactions priced between $75.5001 and $77.0713. The sales totaled approximately $182197. After the trades, Cleminson retains direct ownership of 20,357 Innospec shares. The firm's stock has fallen abou…
Steven B. Klinsky, a director at New Mountain Finance Corp (NASDAQ: NMFC), purchased 237,873 shares of the company on March 5, 2026, at $8.10 per share, a transaction valued at $1,926,771. The stock was trading at $7.98 at the time of reporting, with New Mountain Finance maintaining a market capitalization of $807 million. The Form 4 filing details…
BridgeBio Pharma director Andrea Ellis sold 64,921 shares on March 4, 2026, for $4,211,301 under a Rule 10b5-1 plan while exercising options to acquire the same number of shares at $8.45 each. The company reported Q4 revenue above estimates driven by Attruby sales, recorded a larger-than-expected adjusted loss, and said interim Phase 3 FORTIFY data…
Quest Diagnostics Senior Vice President Karthik Kuppusamy sold 2,628 shares on March 4, 2026, at $204.86 per share for about $538,372 and on the same day received 6,200 shares valued at $1,270,132 as settlement of a performance stock award. The transactions took place with shares trading close to a 52-week high; the company recently reported strong…
Christopher Gustanski, Phinia Inc.'s vice president of Operational Excellence, sold 3,812 shares of common stock on March 4, 2026, in a transaction valued at $277,239. The sale came as Phinia reported fourth-quarter 2025 results that beat on revenue but missed on earnings per share. At the time of reporting, the company's share price was lower than…
Patrick Plewman, senior vice president for Diagnostic Services at Quest Diagnostics (DGX), completed a planned sale of 2,855 shares on March 5, 2026, for $588,729 under a Rule 10b5-1 plan. The transactions followed the settlement of a performance stock award and occurred as the stock traded near its 52-week high. Plewman’s direct ownership after th…
Orthofix Medical Inc. Chief Legal Officer Jorge Andres Cedron sold 2,775 shares of company stock on March 4 and 5, 2026 for a combined $35,341. The two-day sale was executed in multiple transactions at weighted average prices of $12.9163 and $12.5508, and was undertaken to meet tax withholding requirements tied to restricted stock unit settlements.…
William A. Siffermann, a vice president at Nuveen Taxable Municipal Income Fund (NBB), purchased 75 shares at $16.20 on March 4, 2026, a transaction valued at $1,215. After the trade he directly holds 615.1304 shares. At the time of the transaction NBB traded at $15.95 and offered a 7.2% dividend yield, with the fund having paid dividends for 17 co…
William A. Siffermann, a vice president at Nuveen Multi-Asset Income Fund (NMAI), purchased 75 shares at $13.44 per share for $1,008, bringing his direct holdings to 330.0972 shares. The closed-end fund yields 10.55% and, according to InvestingPro, returned 19% over the last year and carries a Financial Health score of "GREAT." Separately, the fund…
Kiersten Medvedich, chief executive of GAIA, INC (NASDAQ:GAIA), bought 1,525 shares of Class A Common Stock on March 5, 2026, for $3.22 per share, a transaction valued at $4,910. The purchase comes as the stock trades near $3.25 and has declined about 43% over the past six months. Separately, Gaia reported fourth-quarter 2025 results that included …
